sFRP2 activates Wnt/β-catenin signaling in cardiac fibroblasts: Differential roles in cell growth, energy metabolism, and extracellular matrix remodeling

American Journal of Physiology - Cell Physiology

Volumn 311, Issue 5, 2016, Pages C710-C719

  Lin, Huey ^a   Angeli, Mia ^a   Chung, Kwang Jin ^a   Ejimadu, Chukwuemeka ^a   Rosa, Angelica Rivera ^a   Lee, Techung ^a  

^a University at Buffalo SUNY   (United States)

Author keywords

Cardiac fibroblast; Extracellular matrix; Matrix metalloproteinase; Secreted Frizzled related protein 2; Wnt

Indexed keywords

ALKALINE PHOSPHATASE; AXIN 2; BETA 2 MICROGLOBULIN; BETA CATENIN; COLLAGEN TYPE 1; COLLAGENASE; COLLAGENASE 1; COLLAGENASE 3; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; INTERSTITIAL COLLAGENASE; LACTIC ACID; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MESSENGER RNA; NEUTROPHIL COLLAGENASE; PROCOLLAGEN C PROTEINASE; SECRETED FRIZZLED RELATED PROTEIN 2; STROMELYSIN; UNCLASSIFIED DRUG; WNT3A PROTEIN; WNT5A PROTEIN; MEMBRANE PROTEIN; METALLOPROTEINASE; SFRP2 PROTEIN, MOUSE; WNT PROTEIN;

ADULT; ANAEROBIC GLYCOLYSIS; ANIMAL CELL; ARTICLE; CELL EXPANSION; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GLUCOSE INTAKE; GLUCOSE METABOLISM; HEART FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; C57BL MOUSE; CARDIAC MUSCLE; CELL CULTURE; FIBROBLAST; FIBROSIS; HEART; HEART INFARCTION; METABOLISM; PHYSIOLOGY;

ANIMALS; BETA CATENIN; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGENASES; ENERGY METABOLISM; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HEART; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; WNT PROTEINS;

EID: 84994666565     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00137.2016     Document Type: Article

References (59)

1. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, Schneider H, Sadowski A, Riener MO, MacDougald OA, Distler O, Schett G, Distler JH. Activation of canonical Wnt signalling is required for TGFβ-mediated fibrosis. Nat Commun 3: 735, 2012.
2. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317: 807-810, 2007.
3. Cadigan KM, Liu YI. Wnt signaling: complexity at the surface. J Cell Sci 119: 395-402, 2006.
4. Chaturvedi M, Kaczmarek L. Mmp-9 inhibition: a therapeutic strategy in ischemic stroke. Mol Neurobiol 49: 563-573, 2014.
5. Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, Roth MG, Amatruda JF, Chen C, Lum L. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5: 100-107, 2009.
6. Chilosi M, Poletti V, Zamo A, Lestani M, Montagna L, Piccoli P, Pedron S, Bertaso M, Scarpa A, Murer B, Cancellieri A, Maestro R, Semenzato G, Doglioni C. Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 162: 1495-1502, 2003.
7. Chung MT, Lai HC, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Liu HS, Chu DW, Lin YW. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol 112: 646-653, 2009.
8. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392, 2002.
9. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG. CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ Res 96: 881-889, 2005.
10. Dobaczewski M, Frangogiannis NG. Chemokines and cardiac fibrosis. Front Biosci 1: 391-405, 2009.
11. Enochson L, Stenberg J, Brittberg M, Lindahl A. GDF5 reduces MMP13 expression in human chondrocytes via DKK1 mediated canonical Wnt signaling inhibition. Osteoarthritis Cartilage 22: 566-577, 2014.
12. Esteve P, Sandonis A, Cardozo M, Malapeira J, Ibanez C, Crespo I, Marcos S, Gonzalez-Garcia S, Toribio ML, Arribas J, Shimono A, Guerrero I, Bovolenta P. SFRPs act as negative modulators of ADAM10 to regulate retinal neurogenesis. Nat Neurosci 14: 562-569, 2011.
13. Foley CJ, Kuliopulos A. Mouse matrix metalloprotease-1a (Mmp1a) gives new insight into MMP function. J Cell Physiol 229: 1875-1880, 2014.
14. Fukasawa H, Yamamoto T, Suzuki H, Togawa A, Ohashi N, Fujigaki Y, Uchida C, Aoki M, Hosono M, Kitagawa M, Hishida A. Treatment with anti-TGFβ antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGFβ signaling. Kidney Int 65: 63-74, 2004.
15. He W, Dai C, Li Y, Zeng G, Monga SP, Liu Y. Wnt/β-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20: 765-776, 2009.
16. Hopkins DR, Keles S, Greenspan DS. The bone morphogenetic protein 1/Tolloid-like metalloproteinases. Matrix Biol 26: 508-523, 2007.
17. Hu J, Van den Steen PE, Sang QX, Opdenakker G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov 6: 480-498, 2007.
18. Hughes BG, Schulz R. Targeting MMP-2 to treat ischemic heart injury. Basic Res Cardiol 109: 424, 2014.
19. Kalenik JL, Chen D, Bradley ME, Chen SJ, Lee TC. Yeast two-hybrid cloning of a novel zinc finger protein that interacts with the multifunctional transcription factor YY1. Nucleic Acids Res 25: 843-849, 1997.
20. Kandasamy AD, Chow AK, Ali MA, Schulz R. Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix. Cardiovasc Res 85: 413-423, 2010.
21. Kaviratne M, Hesse M, Leusink M, Cheever AW, Davies SJ, McKerrow JH, Wakefield LM, Letterio JJ, Wynn TA. IL-13 activates a mechanism of tissue fibrosis that is completely TGFβ independent. J Immunol 173: 4020-4029, 2004.
22. Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116: 2627-2634, 2003.
23. Kilinc D, Ozdemir O, Ozdemir S, Korgali E, Koksal B, Uslu A, Gultekin YE. Alterations in promoter methylation status of tumor suppressor HIC1, SFRP2, and DAPK1 genes in prostate carcinomas. DNA Cell Biol 31: 826-832, 2012.
24. Kobayashi K, Luo M, Zhang Y, Wilkes DC, Ge G, Grieskamp T, Yamada C, Liu TC, Huang G, Basson CT, Kispert A, Greenspan DS, Sato TN. Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat Cell Biol 11: 46-55, 2009.
25. Kositprapa C, Zhang B, Berger S, Canty JM, Lee TC. Calpainmediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes. Mol Cell Biochem 214: 47-55, 2000.
26. 1 and activates β-catenin signaling in mouse intestine. J Biol Chem 284: 1234-1241, 2009.
27. Leask A, Abraham DJ. TGFβ signaling and the fibrotic response. FASEB J 18: 816-827, 2004.
28. Lenglet S, Montecucco F, Mach F, Schaller K, Gasche Y, Copin JC. Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke. Thromb Haemost 112: 363-378, 2014.
29. Lescher B, Haenig B, Kispert A. sFRP-2 is a target of the Wnt-4 signaling pathway in the developing metanephric kidney. Dev Dyn 213: 440-451, 1998.
30. Lin H, Shabbir A, Molnar M, Yang J, Marion S, Canty JM, Lee T. Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow-derived mesenchymal stem cells. J Cell Physiol 216: 458-468, 2008.
31. Liu H, Fergusson MM, Wu JJ, Rovira II, Liu J, Gavrilova O, Lu T, Bao J, Han D, Sack MN, Finkel T. Wnt signaling regulates hepatic metabolism. Sci Signal 4: ra6, 2011.
32. 6-/- mice. Am J Pathol 163: 1261-1273, 2003.
33. Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11: 1696-1701, 2006.
34. Malinauskas T, Jones EY. Extracellular modulators of Wnt signalling. Curr Opin Struct Biol 29: 77-84, 2014.
35. Martin S, Lin H, Ejimadu C, Lee T. Tissue-nonspecific alkaline phosphatase (TNAP) as a target of sFRP2 in cardiac fibroblasts. Am J Physiol Cell Physiol 309: C139-C147, 2015.
36. Mastri M, Shah Z, McLaughlin T, Greene CJ, Baum L, Suzuki G, Lee T. Activation of Toll-like receptor 3 (TLR3) amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency. Am J Physiol Cell Physiol 303: C1021-C1033, 2012.
37. Mastri M, Shah Z, Wang W, Hsieh K, Wooldridge B, Suzuki G, Lee T. Secreted Frizzled-related protein 2 (sFRP2) as a target in anti-fibrotic intervention. Am J Physiol Cell Physiol 306: C531-C539, 2014.
38. Meng XM, Nikolic-Paterson DJ, Lan HY. TGFβ: the master regulator of fibrosis. Nat Rev Nephrol 12: 325-338, 2016.
39. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Inhibition of transforming growth factor-β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 32: 247-255, 2000.
40. Otto AM. Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer Metab 4: 5, 2016.
41. Polychronopoulos P, Magiatis P, Skaltsounis AL, Myrianthopoulos V, Mikros E, Tarricone A, Musacchio A, Roe SM, Pearl L, Leost M, Greengard P, Meijer L. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclindependent kinases. J Med Chem 47: 935-946, 2004.
42. Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, Dichgans J, Weller M. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 19: 4210-4220, 2000.
43. Shabbir A, Zisa D, Lin H, Mastri M, Roloff G, Suzuki G, Lee T. Activation of host tissue trophic factors through JAK/STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair. Am J Physiol Heart Circ Physiol 299: H1428-H1438, 2010.
44. Shabbir A, Zisa D, Suzuki G, Lee T. Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol 296: H1888-H1897, 2009.
45. Skah S, Nadjar J, Sirakov M, Plateroti M. The secreted Frizzled-related protein 2 modulates cell fate and the Wnt pathway in the murine intestinal epithelium. Exp Cell Res 330: 56-65, 2015.
46. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87: 1285-1342, 2007.
47. Sun Y, Zhu D, Chen F, Qian M, Wei H, Chen W, Xu J. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment. Oncogene 35: 4321-4334, 2016.
48. Teekakirikul P, Eminaga S, Toka O, Alcalai R, Wang L, Wakimoto H, Nayor M, Konno T, Gorham JM, Wolf CM, Kim JB, Schmitt JP, Molkentin JD, Norris RA, Tager AM, Hoffman SR, Markwald RR, Seidman CE, Seidman JG. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgfβ. J Clin Invest 120: 3520-3529, 2010.
49. Toriseva M, Laato M, Carpen O, Ruohonen ST, Savontaus E, Inada M, Krane SM, Kahari VM. MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability. PLos One 7: e42596, 2012.
50. Toth M, Sohail A, Fridman R. Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Methods Mol Biol 878: 121-135, 2012.
51. von Marschall Z, Fisher LW. Dentin sialophosphoprotein (DSPP) is cleaved into its two natural dentin matrix products by three isoforms of bone morphogenetic protein-1 (BMP1). Matrix Biol 29: 295-303, 2010.
52. von Marschall Z, Fisher LW. Secreted Frizzled-related protein-2 (sFRP2) augments canonical Wnt3a-induced signaling. Biochem Biophys Res Commun 400: 299-304, 2010.
53. Wang X, Gerdes AM. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs. III. Intercalated disc remodeling. J Mol Cell Cardiol 31: 333-343, 1999.
54. Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast- mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10: 15-26, 2013.
55. Wynn TA. Fibrotic disease and the TH1/TH2 paradigm. Nat Rev Immunol 4: 583-594, 2004.
56. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18: 1028-1040, 2012.
57. Yoshino K, Rubin JS, Higinbotham KG, Uren A, Anest V, Plisov SY, Perantoni AO. Secreted Frizzled-related proteins can regulate metanephric development. Mech Dev 102: 45-55, 2001.
58. Zisa D, Shabbir A, Mastri M, Suzuki G, Lee T. Intramuscular VEGF repairs the failing heart: role of host-derived growth factors and mobilization of progenitor cells. Am J Physiol Regul Integr Comp Physiol 297: R1503-R1515, 2009.
59. Zisa D, Shabbir A, Mastri M, Taylor T, Aleksic I, McDaniel M, Suzuki G, Lee T. Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair. Am J Physiol Heart Circ Physiol 301: H2422-H2432, 2011.